Found 6 matching trials
Efficacy of NVA237 Compared to Tiotropium in Patients With Chronic Obstructive Pulmonary Disease (COPD) PHASE4 The purpose of this study is to further figure out differences of glycopyrr...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
Efficacy, Tolerability and Safety of NVA237 in Patients With Chronic Obstructive Pulmonary Disease PHASE3 This study will assess the efficacy, tolerability and safety of NVA237 comp...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
Evaluation of the Efficacy and Safety of QVA149 (110/50 μg o.d.) vs Tiotropium (18 µg o.d.) + Salmeterol/Fluticasone Propionate FDC (50/500 µg b.i.d.) in Patients With Moderate to Severe COPD PHASE4 This study will evaluate the efficacy and safety of QVA149 (110/50 μg o.d.)...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
Efficacy, Safety, and Tolerability of NVA237 Compared to Tiotropium in Patients With Chronic Obstructive Pulmonary Disease (COPD) PHASE3 This study compared the efficacy and safety of NVA237 with tiotropium in pa...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
26 Week Efficacy, Safety and Tolerability Study of Indacaterol in Patients With Chronic Obstructive Pulmonary Disease (COPD) PHASE2 Stage 1 of the study is designed to provide data about the risk-benefit of ...
Show More Location
Pinnacle Research Group, LLC
Learn More & Join Trial
Exacerbation Study PHASE3 This study compares indacaterol with tiotropium in terms of bronchodilation...
Show More Location
Novartis Investigative Site
Learn More & Join Trial